After having heard the report of the contact group, the Executive Committee decided:
- To approve the plan for phase-out of CFCs in the manufacture of pharmaceutical metered-dose inhalers (MDIs) in Pakistan at the amount of US $449,996 plus agency support costs of US $33,750 for UNDP;
- To approve the national strategy for transition to non-CFC MDIs at the amount of US $70,000* plus agency support costs of US $9,100 for UNEP; and
- That the Government of Pakistan would have flexibility in using the funding available for eligible activities it deemed appropriate to achieve the complete phase-out of CFCs in the MDI sector and in accordance with the relevant decisions and guidelines of the Fund.
- This is the corrected amount as indicated in document UNEP/OzL.Pro/ExCom/56/64/Corr.1